Hepatic
iron overload is common in patients undergoing hematopoietic
cell transplantation. We showed previously in a murine model that
transplantation of allogeneic T cells induced
iron deposition and down-regulation of
hepcidin (Hamp) in hepatocytes. We hypothesized that hepatic injury was related to disrupted
iron homeostasis triggered by the interaction of
Fas-ligand, expressed on activated T cells, with Fas on hepatocytes. In the current study, we determined the effects of modified expression of the
Flice inhibitory protein (FLIP long [FLIPL]), which interferes with Fas signaling, on the impact of Fas-initiated signals on the expression of
IL-6 and Stat3 and their downstream target, Hamp. To exclude a possible contribution by other pathways, we used agonistic anti-Fas
antibodies (rather than allogeneic T cells) to trigger Fas signaling. Inhibition of FLIPL by RNA interference resulted, as expected, not only in enhanced hepatocyte apoptosis in response to Fas signals, but also in decreased levels of
IL-6, Stat3, and Hamp. In contrast, overexpression of FLIPL protected hepatocytes against agonistic anti-Fas antibody-mediated apoptosis and increased the levels of
IL-6 and Stat3, thereby maintaining the expression of Hamp in an NF-κB-dependent fashion. In vivo overexpression of FLIPL in the liver via hydrodynamic transfection, similarly, interfered with Fas-initiated apoptosis and prevented down-regulation of
IL-6, Stat3, and Hamp. These data indicate that Fas-dependent signals alter the regulation of
iron homeostasis and suggest that signals initiated by Fas may contribute to peritransplantation
iron accumulation.